BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yim HJ, Suh SJ, Um SH. Current management of hepatocellular carcinoma: An Eastern perspective. World J Gastroenterol 2015; 21(13): 3826-3842 [PMID: 25852267 DOI: 10.3748/wjg.v21.i13.3826]
URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3826.htm
Number Citing Articles
1
Hua Ding, Zhi-Hua Ye, Dong-Yue Wen, Xiao-Liang Huang, Chu-Mei Zeng, Jie Mo, Yi-Qiang Jiang, Jian-Jun Li, Xiao-Yong Cai, Hong Yang, Gang Chen. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significanceMolecular Medicine Reports 2017; 16(4): 5393 doi: 10.3892/mmr.2017.7275
2
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
3
Silvia Brocco, Anna Sara Fraia, Anna Florio, Emilio Quaia. Imaging of the Liver and Intra-hepatic Biliary TractMedical Radiology 2021; : 349 doi: 10.1007/978-3-030-39021-1_15
4
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinomaMedicine 2018; 97(33): e11872 doi: 10.1097/MD.0000000000011872
5
Xuesong Yao, Dong Yan, Huiying Zeng, Dengzhong Liu, Huai Li. Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinomaJournal of Surgical Oncology 2016; 113(6): 672 doi: 10.1002/jso.24215
6
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee. Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample studyPLOS ONE 2019; 14(10): e0223678 doi: 10.1371/journal.pone.0223678
7
Ying Sun, Yu-jun Tan, Zhan-zhao Lu, Bing-bing Li, Cheng-hong Sun, Tao Li, Li-li Zhao, Zhong Liu, Gui-min Zhang, Jing-chun Yao, Jie Li. Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARαFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00268
8
Yuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, Kun-Ming Rau, I-Pei Wu, Chien-Hung Chen, Kwong-Ming Kee, Tsung-Hui Hu, Sheng-Nan Lu. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib useJournal of Gastroenterology and Hepatology 2017; 32(12): 1975 doi: 10.1111/jgh.13783
9
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular CarcinomasAcademic Radiology 2018; 25(4): 423 doi: 10.1016/j.acra.2017.10.018
10
Chaoyong Tu, Wei Chen, Shuqian Wang, Wei Tan, Jingqiang Guo, Chuxiao Shao, Weilin Wang. MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2Journal of Cellular and Molecular Medicine 2019; 23(11): 7190 doi: 10.1111/jcmm.14197
11
Zhiming Zhang, Gaoxiong Ouyang, Peng Wang, Yuan Ren, Yukai Liu, Jun Chen, Yumei Zhang, Jianyong Liu, Lequn Li. Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosisBMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01065-x
12
Hideaki Takeyama, Toru Beppu, Takaaki Higashi, Takayoshi Kaida, Kota Arima, Katsunobu Taki, Katsunori Imai, Hidetoshi Nitta, Hiromitsu Hayashi, Shigeki Nakagawa, Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Motohiko Tanaka, Yutaka Sasaki, Hideo Baba. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinomaSurgery Today 2018; 48(4): 431 doi: 10.1007/s00595-017-1603-x
13
Wei Wang, Yang Wang, Mingxing Liu, Yifan Zhang, Tao Yang, Dongsheng Li, Yinpeng Huang, Qing Li, Guang Bai, Linlin Shi. Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivoJournal of Cellular and Molecular Medicine 2019; 23(1): 586 doi: 10.1111/jcmm.13964
14
Shi-Yan Yan, Yi Zhang, Chao Sun, Hai-Xia Cao, Guang-Ming Li, Yu-Qin Wang, Jian-Gao Fan. The clinical effect and relevant mechanism of combined sorafenib and radiofrequency ablation in the treatment of early small hepatocellular carcinomaOncology Letters 2016; 12(2): 951 doi: 10.3892/ol.2016.4694
15
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisGut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
16
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinomaCancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
17
Dirk J. van Leeuwen, Otto M. van Delden. Ethics and informed consent in patients with hepatocellular carcinoma: Changing roles for hepatologist and radiologistClinical Liver Disease 2015; 6(5): 122 doi: 10.1002/cld.513
18
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic areaWorld Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
19
XIAO-XI KAN, QI LI, XI CHEN, YA-JIE WANG, YU-JIE LI, QING YANG, HONG-BIN XIAO, ZHI-XIN WANG, YING CHEN, XIAO-GANG WENG, WEI-YAN CAI, XIAO-XIN ZHU. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cellsOncology Reports 2016; 35(6): 3480 doi: 10.3892/or.2016.4742
20
Lujun Shen, Mian Xi, Lei Zhao, Xuhui Zhang, Xiuchen Wang, Zhimei Huang, Qifeng Chen, Tianqi Zhang, Jingxian Shen, Mengzhong Liu, Jinhua Huang. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus SorafenibCancers 2018; 10(12): 516 doi: 10.3390/cancers10120516
21
Gao-Xiong Ouyang, Yu-mei Zhang, Shao-Liang Zhu, Peng Wang, Yuan Ren, Jia-Hao Li, Yu-Kai Liu, Jun Chen, Bang-De Xiang, Le-Qun Li, Jian-Yong Liu, Zhi-Ming Zhang. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinomaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31351-3
22
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapyJournal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
23
Wafaa M. Rashed, Mohamed Ahmed Mohamed Kandeil, Mohamed O. Mahmoud, Sameera Ezzat. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overviewJournal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-0016-x
24
Fengping Jiao, Lu Long, Shanlong Ding, Xiaomeng Xie, Le Jia, Fengmin Lu. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCCMicrobial Pathogenesis 2017; 109: 49 doi: 10.1016/j.micpath.2017.04.028
25
Hoon Sik Choi, Ki Mun Kang, Bae Kwon Jeong, Hojin Jeong, Yun Hee Lee, In Bong Ha, Jin Ho Song. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver diseaseAsia-Pacific Journal of Clinical Oncology 2021; 17(3): 209 doi: 10.1111/ajco.13361
26
Minghui Zhou, Shuang Li, Sheng Shi, Shaolong He, Yanni Ma, Wenping Wang. Hepatic targeting of glycyrrhetinic acid via nanomicelles based on stearic acid-modified fenugreek gumArtificial Cells, Nanomedicine, and Biotechnology 2020; 48(1): 1105 doi: 10.1080/21691401.2020.1813740
27
Chi-Yuan Chen, Jia-You Fang, Chin-Chuan Chen, Wen-Yu Chuang, Yann-Lii Leu, Shir-Hwa Ueng, Li-Shan Wei, Shu-Fang Cheng, Chuen Hsueh, Tong-Hong Wang. 2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase ExpressionFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01319
28
Yichen Yang, Yuequn Ma, Meng Yuan, Yonglin Peng, Zhonghai Fang, Ju Wang. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approachLiver International 2021;  doi: 10.1111/liv.14972